Blog
RSS FeedPosted by Michael Wonder on 26 May 2017
Conservatism and the cancer drugs fund
24 May 2017 - Are some patients—and some people— more deserving than others? ...
Posted by Michael Wonder on 01 May 2017
Cancer fund failure highlights the dilemma of drug pricing
1 May 2017 - The challenge is to keep treatments affordable but still encourage innovation. ...
Posted by Michael Wonder on 17 Nov 2016
NICE approves three quarters of CDF group 1 drugs for routine use
17 November 2016 - More than 75% of treatments in the Cancer Drugs Fund which have been looked at again by ...
Posted by Michael Wonder on 04 Oct 2016
Did it matter that the Cancer Drugs Fund was not NICE? A retrospective review
3 October 2016 - This article reviews the means by which the Cancer Drugs Fund made recent funding decisions for cancer ...
Posted by Michael Wonder on 29 Sep 2016
Cancer Drugs Fund requires further reform
27 September 2016 - Reliance on “real world” observational data undermines evidence base for clinical practice. ...
Posted by Michael Wonder on 11 Aug 2016
A novel UK approach to cancer access: yes, no, or maybe?
10 August 2016 - What are the implications of the new, reinvigorated Cancer Drugs Fund, for pharma and patients? ...
Posted by Michael Wonder on 10 Aug 2016
Cancer patients may lose vital drug in crackdown on funding: watchdog reviews 31 treatments that are not usually available on the NHS
10 August 2016 - The drug brentuximab vedotin may no longer be provided on the NHS. ...
Posted by Michael Wonder on 02 Aug 2016
Rare cancer drug which significantly delays progression of advanced thyroid cancer is left off relaunched Cancer Drugs Fund
2 August 2016 - People with radioiodine refractory differentiated thyroid cancer are overlooked as Lenvima (lenvatinib mesylate) is not scheduled for ...
Posted by Michael Wonder on 01 Aug 2016
Make drug makers pay: England’s strategy for cancer medicines
29 July 2016 - Roche, Pfizer concerned new system has no spending limit. ...
Posted by Michael Wonder on 30 Jul 2016
Cancer sufferers may lose access to effective drugs, says support group
29 July 2016 - Medicine regulator NICE will act as gatekeeper for new treatments, leading to fears NHS patients may be ...
Posted by Michael Wonder on 30 Jul 2016
New drugs available after Cancer Drugs Fund revamp
30 July 2016 - The NHS has announced new potentially life-saving medicines that will be made available to patients as part ...
Posted by Michael Wonder on 30 Jul 2016
Controversial CDF revamp launches
29 July 2016 - England's Cancer Drugs Fund reopens under its new model today, but the pharma industry and charities are ...
Posted by Michael Wonder on 08 Jul 2016
Japan's Eisai weighs legal action in UK cancer drug row
8 July 2016 - Japan's Eisai said on Friday it would consider all options, including possible legal action, to fight delays ...
Posted by Michael Wonder on 07 Jul 2016
Pfizer drug wins U.K. support following overhaul of Cancer Fund
7 July 2016 - Drug costs $58,000 a year before discounts from Pfizer. ...
Posted by Michael Wonder on 23 Jun 2016
UK trailing Europe on access to cancer drugs
23 June 2016 - The UK is trailing Europe on cancer spend, survival rates and patient access to new oncology medicines, ...